On this episode of Road to Recovery, we're joined by immunologist Andrew Pekosz, Professor at Johns Hopkins Bloomberg School of Public Health, to discuss the potential of the new drug Molnupiravir.
To learn more about Bloomberg Philanthropies:
TW: https://twitter.com/BloombergDotOrg
IG: https://www.instagram.com/bloombergdotorg
FB: https://www.facebook.com/bloombergdotorg
LI: https://www.linkedin.com/company/bloomberg-philanthropies
https://www.bloomberg.org/
To learn more about Bloomberg Philanthropies:
TW: https://twitter.com/BloombergDotOrg
IG: https://www.instagram.com/bloombergdotorg
FB: https://www.facebook.com/bloombergdotorg
LI: https://www.linkedin.com/company/bloomberg-philanthropies
https://www.bloomberg.org/
- Category
- Health
Be the first to comment